These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3046413)

  • 1. [Amrinone (Wincoram)--a new positive inotropic and vasodilator agent].
    Hess W
    Anaesthesist; 1988 Jul; 37(7):400-7. PubMed ID: 3046413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of bipyridine phosphodiesterase III inhibitors.
    Honerjäger P; Nawrath H
    Eur J Anaesthesiol Suppl; 1992; 5():7-14. PubMed ID: 1600969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of amrinone, a new non-digitalic positive inotropic agent, on the efficiency and coronary circulation of the heart].
    Bárcenas L; Kabela E
    Arch Inst Cardiol Mex; 1984; 54(5):431-40. PubMed ID: 6517640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of heart failure in cardiac surgical patients: amrinone and other pharmacologic agents.
    LeDoux D
    Prog Cardiovasc Nurs; 1990; 5(3):78-83. PubMed ID: 2267243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of amrinone in acute severe cardiac failure.
    Heuer H; Frenking B; Gülker H
    Arzneimittelforschung; 1988 Apr; 38(4):567-70. PubMed ID: 3401270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
    Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative experience with amrinone.
    Levy JH; Bailey JM
    Eur J Anaesthesiol Suppl; 1992; 5():15-9. PubMed ID: 1600963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of inodilators.
    Dei Cas L; Metra M; Visioli O
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of amrinone versus dobutamine on myocardial mechanics and energetics after hypothermic global ischemia.
    Ko W; Zelano JA; Fahey AL; Berman K; Lang D; Isom OW; Krieger KH
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1015-24. PubMed ID: 8501930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of OPC-18790, a new positive inotropic agent, on energetics in the ischaemic canine heart: a 31P-MRS study.
    Ishikawa M; Mori T; Itoh S; Fujiki H; Koga K; Tominaga M; Yabuuchi Y
    Cardiovasc Res; 1995 Aug; 30(2):299-306. PubMed ID: 7585818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
    Rohde E; Wiesner B; Muschick P
    Pharmazie; 1993 Sep; 48(9):690-4. PubMed ID: 8234405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New inotropic-vasodilating drugs in acute and chronic heart failure.
    Goenen MJ
    Ann Med Interne (Paris); 1986; 137(3):229-34. PubMed ID: 3767191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute effect of dobutamine and amrinone on hemodynamics and splanchnic perfusion in septic shock patients].
    Hernández G; Gigoux J; Bugedo G; Castillo L; Bruhn A; Tomicic V; Dagnino J
    Rev Med Chil; 1999 Jun; 127(6):660-6. PubMed ID: 10513074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelial-derived nitric oxide mediates the peripheral vasodilatory effects of amrinone in humans].
    Sakane T; Ishibashi Y; Shimada T; Inoue S; Sugamori T; Hirano Y; Takahashi N; Ohata S; Asanuma T; Kato H; Yoshitomi H; Sano K; Murakami Y; Murakami R
    J Cardiol; 1999 Jan; 33(1):13-9. PubMed ID: 10028457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.